Recent Updates
Recently added Catalysts
ELUT Positive Sentiment Score: 65/100

Elutia to Report Fourth Quarter and Full Year 2023 Financial Results on Thursday, March 7, 2024

Thursday, February 22, 2024 1 min read
Key Takeaway: Elutia Inc. has announced that it will report its financial results for the fourth quarter and full year 2023 on March 7, 2024, after market close. A conference call and webcast will follow at 4:30 p.m. ET for investors to discuss the results. The company, known for its drug-eluting biomatrix products, emphasizes its commitment to advancing medical technology and improving patient care. Access details for the conference call have been provided to both U.S. and international investors.

Market Sentiment Analysis

POSITIVE FACTORS

  • Elutia is preparing to release its financial results, indicating transparency with investors.
  • The scheduled conference call shows ongoing communication with stakeholders.
  • Elutia's mission of improving compatibility in medical devices addresses a significant healthcare need.

Full Press Release Details

SILVER SPRING, Md., Feb. 22, 2024 (GLOBE NEWSWIRE) -- Elutia Inc. (Nasdaq: ELUT) (“Elutia”), a company pioneering drug-eluting biomatrix products, today announced that it will release its fourth quarter and full year 2023 financial results after market close on Thursday, March 7, 2024. Members of the Company’s management team will host a conference call and webcast starting at 4:30 p.m. Eastern Time / 1:30 p.m. Pacific Time on the same day.
The conference call can be accessed using the following information:
U.S. Investors: 877-407-8029
International Investors: 201-689-8029
Conference ID: 13744499
Please log in approximately 10 minutes prior to the scheduled start time. A live and archived webcast of the event will be available on the “Investors” section of the Elutia website at https://investors.elutia.com/.
Elutia develops and commercializes biologic products to improve compatibility between medical devices and the patients who need them. With a growing population in need of implantable technologies, Elutia’s mission is humanizing medicine so patients can thrive without compromise. For more information, visit www.Elutia.com.
matt.steinberg@finnpartners.com

Frequently Asked Questions

When will Elutia release its financial results for 2023?

Elutia will release its financial results on March 7, 2024, after market close.

What time is Elutia's conference call on March 7, 2024?

The conference call is scheduled for 4:30 p.m. Eastern Time.

How can I access the conference call for Elutia?

You can call 877-407-8029 for U.S. investors or 201-689-8029 for international investors.

Where can I find Elutia's live webcast?

The live webcast can be found on the 'Investors' section of Elutia's website.

What is Elutia's mission in the medical field?

Elutia aims to enhance compatibility between medical devices and patients.

Tags: ELUT Viatris Investor Conferences Healthcare Elutia financial results biologic products implantable technologies medical devices
Last updated: Feb 22, 2024